These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
407 related articles for article (PubMed ID: 20570927)
1. Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects. Zhang W; Zhu XD; Sun HC; Xiong YQ; Zhuang PY; Xu HX; Kong LQ; Wang L; Wu WZ; Tang ZY Clin Cancer Res; 2010 Jul; 16(13):3420-30. PubMed ID: 20570927 [TBL] [Abstract][Full Text] [Related]
2. Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma. Wang Z; Zhou J; Fan J; Qiu SJ; Yu Y; Huang XW; Tang ZY Clin Cancer Res; 2008 Aug; 14(16):5124-30. PubMed ID: 18698030 [TBL] [Abstract][Full Text] [Related]
3. Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling. Man K; Ng KT; Xu A; Cheng Q; Lo CM; Xiao JW; Sun BS; Lim ZX; Cheung JS; Wu EX; Sun CK; Poon RT; Fan ST Clin Cancer Res; 2010 Feb; 16(3):967-77. PubMed ID: 20103676 [TBL] [Abstract][Full Text] [Related]
4. [Study on the inhibitory effect of small tripeptide CMS024 on tumor growth and metastasis in nude mice model of human hepatocellular carcinoma metastasis]. Li Y; Tang ZY; Wang L; Yao Z; Lu R; Xue Q; Gao DM; Chen J Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(8):675-9. PubMed ID: 15130313 [TBL] [Abstract][Full Text] [Related]
5. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Liu L; Cao Y; Chen C; Zhang X; McNabola A; Wilkie D; Wilhelm S; Lynch M; Carter C Cancer Res; 2006 Dec; 66(24):11851-8. PubMed ID: 17178882 [TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells. Blivet-Van Eggelpoël MJ; Chettouh H; Fartoux L; Aoudjehane L; Barbu V; Rey C; Priam S; Housset C; Rosmorduc O; Desbois-Mouthon C J Hepatol; 2012 Jul; 57(1):108-15. PubMed ID: 22414764 [TBL] [Abstract][Full Text] [Related]
7. Interferon alpha inhibits hepatocellular carcinoma growth through inducing apoptosis and interfering with adhesion of tumor endothelial cells. Zhang T; Sun HC; Zhou HY; Luo JT; Zhang BL; Wang P; Wang L; Qin LX; Ren N; Ye SL; Li Q; Tang ZY Cancer Lett; 2010 Apr; 290(2):204-10. PubMed ID: 19822391 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of antitumoral properties of the protease inhibitor indinavir in a murine model of hepatocarcinoma. Esposito V; Palescandolo E; Spugnini EP; Montesarchio V; De Luca A; Cardillo I; Cortese G; Baldi A; Chirianni A Clin Cancer Res; 2006 Apr; 12(8):2634-9. PubMed ID: 16638877 [TBL] [Abstract][Full Text] [Related]
10. Suppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-A and VEGF-C with a receptor-immunoglobulin fusion protein. Zhang D; Li B; Shi J; Zhao L; Zhang X; Wang C; Hou S; Qian W; Kou G; Wang H; Guo Y Cancer Res; 2010 Mar; 70(6):2495-503. PubMed ID: 20197464 [TBL] [Abstract][Full Text] [Related]
11. Chitosan nanoparticles inhibit the growth of human hepatocellular carcinoma xenografts through an antiangiogenic mechanism. Xu Y; Wen Z; Xu Z Anticancer Res; 2009 Dec; 29(12):5103-9. PubMed ID: 20044623 [TBL] [Abstract][Full Text] [Related]
12. Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors. Coxon A; Bush T; Saffran D; Kaufman S; Belmontes B; Rex K; Hughes P; Caenepeel S; Rottman JB; Tasker A; Patel V; Kendall R; Radinsky R; Polverino A Clin Cancer Res; 2009 Jan; 15(1):110-8. PubMed ID: 19118038 [TBL] [Abstract][Full Text] [Related]
13. Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice. Aharinejad S; Paulus P; Sioud M; Hofmann M; Zins K; Schäfer R; Stanley ER; Abraham D Cancer Res; 2004 Aug; 64(15):5378-84. PubMed ID: 15289345 [TBL] [Abstract][Full Text] [Related]
14. [Inhibition of growth and metastasis of hepatocellular carcinoma by rapamycin: experiment with mice]. Wang Z; Fan J; Zhou J; Wu ZQ; Qiu SJ; Yu Y; Huang XW; Tang ZY Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1666-70. PubMed ID: 16854316 [TBL] [Abstract][Full Text] [Related]
15. Antitumor efficacy of recombinant human interleukin-2 combined with sorafenib against mouse renal cell carcinoma. Iguchi M; Matsumoto M; Hojo K; Wada T; Matsuo Y; Arimura A; Abe K Jpn J Clin Oncol; 2009 May; 39(5):303-9. PubMed ID: 19336449 [TBL] [Abstract][Full Text] [Related]
16. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models. Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925 [TBL] [Abstract][Full Text] [Related]
17. [Effects of Rapamycin on angiogenesis and tumor progression in human hepatocellular carcinoma implantation mice]. Zhang J; Li H; Wang GS; Jiang N; Yang Y; Chen GH Zhonghua Wai Ke Za Zhi; 2009 Sep; 47(18):1403-5. PubMed ID: 20092777 [TBL] [Abstract][Full Text] [Related]
18. [Vasoinhibitory effect of daltepartin sodium on human hepatocellular carcinoma in nude mice]. Yan J; Zheng Q; Wang Y; Lu HF; Xue Q; Tang ZY Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):359-61. PubMed ID: 15918971 [TBL] [Abstract][Full Text] [Related]
19. [Effect of thalidomide on tumor growth in mouse hepatoma H22 model]. Zhai Y; Lu ZJ Ai Zheng; 2003 Dec; 22(12):1301-6. PubMed ID: 14693056 [TBL] [Abstract][Full Text] [Related]
20. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584. Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]